Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
132 participants
OBSERVATIONAL
2010-11-30
2013-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
However, the role of sodium intake in MS has not been investigated. In this study we investigate the effect of sodium intake in Multiple Sclerosis (MS) clinical and radiological activity.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Dietary Salt Intake on Immune Function in Patients With Multiple Sclerosis
NCT02282878
Physiological Effects of N-Acetyl Cysteine in Patients With Multiple Sclerosis
NCT03032601
The Effect of a Mediterranean Diet on Quality of Life in Multiple Sclerosis Patients
NCT06764563
Evaluation of Nutritional Status and Fatigue in Patients With Multiple Sclerosis
NCT02008669
A Specialized Diet for Multiple Sclerosis
NCT07033975
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
MS patients
MS patients
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subject has diagnosis of relapsing-remitting MS according to McDonald criteria (2010)
Exclusion Criteria
18 Years
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mauricio F. Farez
Research Associate
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mauricio F Farez, MD MPH
Role: PRINCIPAL_INVESTIGATOR
Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
FLENI
Buenos Aires, , Argentina
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Salt-1
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
Salt
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.